-
2
-
-
12444279265
-
On the origin of cancer cells
-
Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
-
(1956)
Science
, vol.123
, pp. 309-314
-
-
Warburg, O.1
-
3
-
-
66249108601
-
Understanding the Warburg effect: the metabolic requirements of cell proliferation
-
Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
-
(2009)
Science
, vol.324
, pp. 1029-1033
-
-
Vander Heiden, M.G.1
Cantley, L.C.2
Thompson, C.B.3
-
4
-
-
17844383964
-
Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements
-
Ramanathan A., Wang C., Schreiber S.L. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci USA 2005, 102:5992-5997.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 5992-5997
-
-
Ramanathan, A.1
Wang, C.2
Schreiber, S.L.3
-
5
-
-
2542561169
-
Akt stimulates aerobic glycolysis in cancer cells
-
Elstrom R.L., Bauer D.E., Buzzai M., Karnauskas R., Harris M.H., Plas D.R., et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 2004, 64:3892-3899.
-
(2004)
Cancer Res
, vol.64
, pp. 3892-3899
-
-
Elstrom, R.L.1
Bauer, D.E.2
Buzzai, M.3
Karnauskas, R.4
Harris, M.H.5
Plas, D.R.6
-
6
-
-
40749163248
-
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
-
Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
-
(2008)
Nature
, vol.452
, pp. 230-233
-
-
Christofk, H.R.1
Vander Heiden, M.G.2
Harris, M.H.3
Ramanathan, A.4
Gerszten, R.E.5
Wei, R.6
-
7
-
-
0022930036
-
The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing
-
Noguchi T., Inoue H., Tanaka T. The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J Biol Chem 1986, 261:13807-13812.
-
(1986)
J Biol Chem
, vol.261
, pp. 13807-13812
-
-
Noguchi, T.1
Inoue, H.2
Tanaka, T.3
-
9
-
-
0030921103
-
C-Myc transactivation of LDH-A: implications for tumor metabolism and growth
-
Shim H., Dolde C., Lewis B.C., Wu C.S., Dang G., Jungmann R.A., et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci USA 1997, 94:6658-6663.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 6658-6663
-
-
Shim, H.1
Dolde, C.2
Lewis, B.C.3
Wu, C.S.4
Dang, G.5
Jungmann, R.A.6
-
10
-
-
37549032776
-
The interplay between MYC and HIF in cancer
-
Dang C.V., Kim J.W., Gao P., Yustein J. The interplay between MYC and HIF in cancer. Nat Rev Cancer 2008, 8:51-56.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 51-56
-
-
Dang, C.V.1
Kim, J.W.2
Gao, P.3
Yustein, J.4
-
12
-
-
0033587146
-
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
-
Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271-275.
-
(1999)
Nature
, vol.399
, pp. 271-275
-
-
Maxwell, P.H.1
Wiesener, M.S.2
Chang, G.W.3
Clifford, S.C.4
Vaux, E.C.5
Cockman, M.E.6
-
13
-
-
33845803145
-
Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis
-
Tanaka H., Yamamoto M., Hashimoto N., Miyakoshi M., Tamakawa S., Yoshie M., et al. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Cancer Res 2006, 66:11263-11270.
-
(2006)
Cancer Res
, vol.66
, pp. 11263-11270
-
-
Tanaka, H.1
Yamamoto, M.2
Hashimoto, N.3
Miyakoshi, M.4
Tamakawa, S.5
Yoshie, M.6
-
14
-
-
0035012605
-
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
-
Laughner E., Taghavi P., Chiles K., Mahon P.C., Semenza G.L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001, 21:3995-4004.
-
(2001)
Mol Cell Biol
, vol.21
, pp. 3995-4004
-
-
Laughner, E.1
Taghavi, P.2
Chiles, K.3
Mahon, P.C.4
Semenza, G.L.5
-
15
-
-
61749083162
-
HIF-1alpha determines the metastatic potential of gastric cancer cells
-
Rohwer N., Lobitz S., Daskalow K., Jons T., Vieth M., Schlag P.M., et al. HIF-1alpha determines the metastatic potential of gastric cancer cells. Br J Cancer 2009, 100:772-781.
-
(2009)
Br J Cancer
, vol.100
, pp. 772-781
-
-
Rohwer, N.1
Lobitz, S.2
Daskalow, K.3
Jons, T.4
Vieth, M.5
Schlag, P.M.6
-
16
-
-
33847023140
-
Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting
-
Dewhirst M.W. Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. Cancer Res 2007, 67:854-855.
-
(2007)
Cancer Res
, vol.67
, pp. 854-855
-
-
Dewhirst, M.W.1
-
17
-
-
77957786826
-
Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB
-
Rohwer N., Dame C., Haugstetter A., Wiedenmann B., Detjen K., Schmitt C.A., et al. Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB. PLoS One 2010, 5:e12038.
-
(2010)
PLoS One
, vol.5
-
-
Rohwer, N.1
Dame, C.2
Haugstetter, A.3
Wiedenmann, B.4
Detjen, K.5
Schmitt, C.A.6
-
18
-
-
78149330949
-
HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
-
Corzo C.A., Condamine T., Lu L., Cotter M.J., Youn J.I., Cheng P., et al. HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med 2010, 207:2439-2453.
-
(2010)
J Exp Med
, vol.207
, pp. 2439-2453
-
-
Corzo, C.A.1
Condamine, T.2
Lu, L.3
Cotter, M.J.4
Youn, J.I.5
Cheng, P.6
-
19
-
-
4944244259
-
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues
-
Murdoch C., Giannoudis A., Lewis C.E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004, 104:2224-2234.
-
(2004)
Blood
, vol.104
, pp. 2224-2234
-
-
Murdoch, C.1
Giannoudis, A.2
Lewis, C.E.3
-
21
-
-
47749114537
-
Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism
-
Baba M., Inoue M., Itoh K., Nishizawa Y. Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism. Biochem Biophys Res Commun 2008, 374:111-116.
-
(2008)
Biochem Biophys Res Commun
, vol.374
, pp. 111-116
-
-
Baba, M.1
Inoue, M.2
Itoh, K.3
Nishizawa, Y.4
-
22
-
-
60549091044
-
Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells
-
Slomiany M.G., Grass G.D., Robertson A.D., Yang X.Y., Maria B.L., Beeson C., et al. Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells. Cancer Res 2009, 69:1293-1301.
-
(2009)
Cancer Res
, vol.69
, pp. 1293-1301
-
-
Slomiany, M.G.1
Grass, G.D.2
Robertson, A.D.3
Yang, X.Y.4
Maria, B.L.5
Beeson, C.6
-
23
-
-
50249166551
-
Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9
-
Sienel W., Polzer B., Elshawi K., Lindner M., Morresi-Hauf A., Vay C., et al. Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9. Mod Pathol 2008, 21:1130-1138.
-
(2008)
Mod Pathol
, vol.21
, pp. 1130-1138
-
-
Sienel, W.1
Polzer, B.2
Elshawi, K.3
Lindner, M.4
Morresi-Hauf, A.5
Vay, C.6
-
24
-
-
80053640489
-
CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors
-
Le Floch R., Chiche J., Marchiq I., Naiken T., Ilk K., Murray C.M., et al. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc Natl Acad Sci USA 2011, 108:16663-16668.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 16663-16668
-
-
Le Floch, R.1
Chiche, J.2
Marchiq, I.3
Naiken, T.4
Ilk, K.5
Murray, C.M.6
-
25
-
-
65349095566
-
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis
-
Amann T., Maegdefrau U., Hartmann A., Agaimy A., Marienhagen J., Weiss T.S., et al. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol 2009, 174:1544-1552.
-
(2009)
Am J Pathol
, vol.174
, pp. 1544-1552
-
-
Amann, T.1
Maegdefrau, U.2
Hartmann, A.3
Agaimy, A.4
Marienhagen, J.5
Weiss, T.S.6
-
26
-
-
70349331678
-
Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells
-
Yun J., Rago C., Cheong I., Pagliarini R., Angenendt P., Rajagopalan H., et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 2009, 325:1555-1559.
-
(2009)
Science
, vol.325
, pp. 1555-1559
-
-
Yun, J.1
Rago, C.2
Cheong, I.3
Pagliarini, R.4
Angenendt, P.5
Rajagopalan, H.6
-
27
-
-
38549175087
-
Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha
-
Lidgren A., Bergh A., Grankvist K., Rasmuson T., Ljungberg B. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha. BJU Int 2008, 101:480-484.
-
(2008)
BJU Int
, vol.101
, pp. 480-484
-
-
Lidgren, A.1
Bergh, A.2
Grankvist, K.3
Rasmuson, T.4
Ljungberg, B.5
-
28
-
-
79952470343
-
Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor
-
Singer K., Kastenberger M., Gottfried E., Hammerschmied C.G., Buttner M., Aigner M., et al. Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor. Int J Cancer 2011, 128:2085-2095.
-
(2011)
Int J Cancer
, vol.128
, pp. 2085-2095
-
-
Singer, K.1
Kastenberger, M.2
Gottfried, E.3
Hammerschmied, C.G.4
Buttner, M.5
Aigner, M.6
-
29
-
-
0034652620
-
High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers
-
Walenta S., Wetterling M., Lehrke M., Schwickert G., Sundfor K., Rofstad E.K., et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 2000, 60:916-921.
-
(2000)
Cancer Res
, vol.60
, pp. 916-921
-
-
Walenta, S.1
Wetterling, M.2
Lehrke, M.3
Schwickert, G.4
Sundfor, K.5
Rofstad, E.K.6
-
30
-
-
0031029634
-
Correlation of high lactate levels in head and neck tumors with incidence of metastasis
-
Walenta S., Salameh A., Lyng H., Evensen J.F., Mitze M., Rofstad E.K., et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 1997, 150:409-415.
-
(1997)
Am J Pathol
, vol.150
, pp. 409-415
-
-
Walenta, S.1
Salameh, A.2
Lyng, H.3
Evensen, J.F.4
Mitze, M.5
Rofstad, E.K.6
-
31
-
-
79954537559
-
Ketones and lactate increase cancer cell stemness, driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics
-
Martinez-Outschoorn U.E., Prisco M., Ertel A., Tsirigos A., Lin Z., Pavlides S., et al. Ketones and lactate increase cancer cell stemness, driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics. Cell Cycle 2011, 10:1271-1286.
-
(2011)
Cell Cycle
, vol.10
, pp. 1271-1286
-
-
Martinez-Outschoorn, U.E.1
Prisco, M.2
Ertel, A.3
Tsirigos, A.4
Lin, Z.5
Pavlides, S.6
-
32
-
-
79960029992
-
Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release
-
Goetze K., Walenta S., Ksiazkiewicz M., Kunz-Schughart L.A., Mueller-Klieser W. Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int J Oncol 2011, 39:453-463.
-
(2011)
Int J Oncol
, vol.39
, pp. 453-463
-
-
Goetze, K.1
Walenta, S.2
Ksiazkiewicz, M.3
Kunz-Schughart, L.A.4
Mueller-Klieser, W.5
-
33
-
-
68949092126
-
Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2
-
Baumann F., Leukel P., Doerfelt A., Beier C.P., Dettmer K., Oefner P.J., et al. Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncol 2009, 11:368-380.
-
(2009)
Neuro Oncol
, vol.11
, pp. 368-380
-
-
Baumann, F.1
Leukel, P.2
Doerfelt, A.3
Beier, C.P.4
Dettmer, K.5
Oefner, P.J.6
-
34
-
-
33745535252
-
Tumor microenvironment modulates hyaluronan expression: the lactate effect
-
Rudrabhatla S.R., Mahaffey C.L., Mummert M.E. Tumor microenvironment modulates hyaluronan expression: the lactate effect. J Invest Dermatol 2006, 126:1378-1387.
-
(2006)
J Invest Dermatol
, vol.126
, pp. 1378-1387
-
-
Rudrabhatla, S.R.1
Mahaffey, C.L.2
Mummert, M.E.3
-
35
-
-
74549186565
-
Glycolytic metabolism and tumour response to fractionated irradiation
-
Sattler U.G., Meyer S.S., Quennet V., Hoerner C., Knoerzer H., Fabian C., et al. Glycolytic metabolism and tumour response to fractionated irradiation. Radiother Oncol 2010, 94:102-109.
-
(2010)
Radiother Oncol
, vol.94
, pp. 102-109
-
-
Sattler, U.G.1
Meyer, S.S.2
Quennet, V.3
Hoerner, C.4
Knoerzer, H.5
Fabian, C.6
-
36
-
-
33344467760
-
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
-
Gottfried E., Kunz-Schughart L.A., Ebner S., Mueller-Klieser W., Hoves S., Andreesen R., et al. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 2006, 107:2013-2021.
-
(2006)
Blood
, vol.107
, pp. 2013-2021
-
-
Gottfried, E.1
Kunz-Schughart, L.A.2
Ebner, S.3
Mueller-Klieser, W.4
Hoves, S.5
Andreesen, R.6
-
37
-
-
0037824664
-
Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration
-
de la R.G., Longo N., Rodriguez-Fernandez J.L., Puig-Kroger A., Pineda A., Corbi A.L., et al. Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration. J Leukoc Biol 2003, 73:639-649.
-
(2003)
J Leukoc Biol
, vol.73
, pp. 639-649
-
-
de la, R.G.1
Longo, N.2
Rodriguez-Fernandez, J.L.3
Puig-Kroger, A.4
Pineda, A.5
Corbi, A.L.6
-
38
-
-
0031414347
-
Effect of bicarbonate-based dialysis solutions on intracellular pH (pHi) and TNFalpha production by peritoneal macrophages
-
Rogachev B., Hausmann M.J., Yulzari R., Weiler M., Holmes C., Faict D., et al. Effect of bicarbonate-based dialysis solutions on intracellular pH (pHi) and TNFalpha production by peritoneal macrophages. Perit Dial Int 1997, 17:546-553.
-
(1997)
Perit Dial Int
, vol.17
, pp. 546-553
-
-
Rogachev, B.1
Hausmann, M.J.2
Yulzari, R.3
Weiler, M.4
Holmes, C.5
Faict, D.6
-
39
-
-
77949324759
-
Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes
-
Dietl K., Renner K., Dettmer K., Timischl B., Eberhart K., Dorn C., et al. Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J Immunol 2010, 184:1200-1209.
-
(2010)
J Immunol
, vol.184
, pp. 1200-1209
-
-
Dietl, K.1
Renner, K.2
Dettmer, K.3
Timischl, B.4
Eberhart, K.5
Dorn, C.6
-
40
-
-
47249118348
-
Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway
-
Shime H., Yabu M., Akazawa T., Kodama K., Matsumoto M., Seya T., et al. Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J Immunol 2008, 180:7175-7183.
-
(2008)
J Immunol
, vol.180
, pp. 7175-7183
-
-
Shime, H.1
Yabu, M.2
Akazawa, T.3
Kodama, K.4
Matsumoto, M.5
Seya, T.6
-
41
-
-
33746534417
-
IL-23 promotes tumour incidence and growth
-
Langowski J.L., Zhang X., Wu L., Mattson J.D., Chen T., Smith K., et al. IL-23 promotes tumour incidence and growth. Nature 2006, 442:461-465.
-
(2006)
Nature
, vol.442
, pp. 461-465
-
-
Langowski, J.L.1
Zhang, X.2
Wu, L.3
Mattson, J.D.4
Chen, T.5
Smith, K.6
-
42
-
-
61449221901
-
Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation
-
Samuvel D.J., Sundararaj K.P., Nareika A., Lopes-Virella M.F., Huang Y. Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation. J Immunol 2009, 182:2476-2484.
-
(2009)
J Immunol
, vol.182
, pp. 2476-2484
-
-
Samuvel, D.J.1
Sundararaj, K.P.2
Nareika, A.3
Lopes-Virella, M.F.4
Huang, Y.5
-
43
-
-
34247352844
-
Inhibitory effect of tumor cell-derived lactic acid on human T cells
-
Fischer K., Hoffmann P., Voelkl S., Meidenbauer N., Ammer J., Edinger M., et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 2007, 109:3812-3819.
-
(2007)
Blood
, vol.109
, pp. 3812-3819
-
-
Fischer, K.1
Hoffmann, P.2
Voelkl, S.3
Meidenbauer, N.4
Ammer, J.5
Edinger, M.6
-
44
-
-
34247233078
-
Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes
-
Feder-Mengus C., Ghosh S., Weber W.P., Wyler S., Zajac P., Terracciano L., et al. Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes. Br J Cancer 2007, 96:1072-1082.
-
(2007)
Br J Cancer
, vol.96
, pp. 1072-1082
-
-
Feder-Mengus, C.1
Ghosh, S.2
Weber, W.P.3
Wyler, S.4
Zajac, P.5
Terracciano, L.6
-
45
-
-
84862151000
-
Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation
-
Mendler A.N., Hu B., Prinz P.U., Kreutz M., Gottfried E., Noessner E. Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation. Int J Cancer 2011.
-
(2011)
Int J Cancer
-
-
Mendler, A.N.1
Hu, B.2
Prinz, P.U.3
Kreutz, M.4
Gottfried, E.5
Noessner, E.6
-
46
-
-
0027418622
-
Transport of lactate and other monocarboxylates across mammalian plasma membranes
-
Poole R.C., Halestrap A.P. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am J Physiol 1993, 264:C761-C782.
-
(1993)
Am J Physiol
, vol.264
-
-
Poole, R.C.1
Halestrap, A.P.2
-
47
-
-
8144228566
-
Why do cancers have high aerobic glycolysis
-
Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis. Nat Rev Cancer 2004, 4:891-899.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 891-899
-
-
Gatenby, R.A.1
Gillies, R.J.2
-
48
-
-
77951228314
-
The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy
-
DeClerck K., Elble R.C. The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy. Front Biosci 2010, 15:213-225.
-
(2010)
Front Biosci
, vol.15
, pp. 213-225
-
-
DeClerck, K.1
Elble, R.C.2
-
49
-
-
65549166946
-
Bicarbonate increases tumor pH and inhibits spontaneous metastases
-
Robey I.F., Baggett B.K., Kirkpatrick N.D., Roe D.J., Dosescu J., Sloane B.F., et al. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 2009, 69:2260-2268.
-
(2009)
Cancer Res
, vol.69
, pp. 2260-2268
-
-
Robey, I.F.1
Baggett, B.K.2
Kirkpatrick, N.D.3
Roe, D.J.4
Dosescu, J.5
Sloane, B.F.6
-
50
-
-
77953463274
-
PH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity
-
De Milito A., Canese R., Marino M.L., Borghi M., Iero M., Villa A., et al. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer 2010, 127:207-219.
-
(2010)
Int J Cancer
, vol.127
, pp. 207-219
-
-
De Milito, A.1
Canese, R.2
Marino, M.L.3
Borghi, M.4
Iero, M.5
Villa, A.6
-
51
-
-
0035881307
-
Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo
-
Fukumura D., Xu L., Chen Y., Gohongi T., Seed B., Jain R.K. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 2001, 61:6020-6024.
-
(2001)
Cancer Res
, vol.61
, pp. 6020-6024
-
-
Fukumura, D.1
Xu, L.2
Chen, Y.3
Gohongi, T.4
Seed, B.5
Jain, R.K.6
-
52
-
-
0035071662
-
The effects of extracellular pH on immune function
-
Lardner A. The effects of extracellular pH on immune function. J Leukoc Biol 2001, 69:522-530.
-
(2001)
J Leukoc Biol
, vol.69
, pp. 522-530
-
-
Lardner, A.1
-
53
-
-
2942531063
-
Mitochondrial defects in cancer
-
Carew J.S., Huang P. Mitochondrial defects in cancer. Mol Cancer 2002, 1:9.
-
(2002)
Mol Cancer
, vol.1
, pp. 9
-
-
Carew, J.S.1
Huang, P.2
-
54
-
-
79955571599
-
Post-transcriptional regulation of the mitochondrial H(+)-ATP synthase: a key regulator of the metabolic phenotype in cancer
-
Willers I.M., Cuezva J.M. Post-transcriptional regulation of the mitochondrial H(+)-ATP synthase: a key regulator of the metabolic phenotype in cancer. Biochim Biophys Acta 2011, 1807:543-551.
-
(2011)
Biochim Biophys Acta
, vol.1807
, pp. 543-551
-
-
Willers, I.M.1
Cuezva, J.M.2
-
55
-
-
27944502154
-
Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis
-
Isidoro A., Casado E., Redondo A., Acebo P., Espinosa E., Alonso A.M., et al. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis 2005, 26:2095-2104.
-
(2005)
Carcinogenesis
, vol.26
, pp. 2095-2104
-
-
Isidoro, A.1
Casado, E.2
Redondo, A.3
Acebo, P.4
Espinosa, E.5
Alonso, A.M.6
-
56
-
-
29644448054
-
Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice
-
Thierbach R., Schulz T.J., Isken F., Voigt A., Mietzner B., Drewes G., et al. Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. Hum Mol Genet 2005, 14:3857-3864.
-
(2005)
Hum Mol Genet
, vol.14
, pp. 3857-3864
-
-
Thierbach, R.1
Schulz, T.J.2
Isken, F.3
Voigt, A.4
Mietzner, B.5
Drewes, G.6
-
57
-
-
84855878565
-
P53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2
-
Contractor T., Harris C.R. p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2. Cancer Res 2012, 72:560-567.
-
(2012)
Cancer Res
, vol.72
, pp. 560-567
-
-
Contractor, T.1
Harris, C.R.2
-
58
-
-
33745149291
-
P53 regulates mitochondrial respiration
-
Matoba S., Kang J.G., Patino W.D., Wragg A., Boehm M., Gavrilova O., et al. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653.
-
(2006)
Science
, vol.312
, pp. 1650-1653
-
-
Matoba, S.1
Kang, J.G.2
Patino, W.D.3
Wragg, A.4
Boehm, M.5
Gavrilova, O.6
-
60
-
-
18544365990
-
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
-
Tomlinson I.P., Alam N.A., Rowan A.J., Barclay E., Jaeger E.E., Kelsell D., et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002, 30:406-410.
-
(2002)
Nat Genet
, vol.30
, pp. 406-410
-
-
Tomlinson, I.P.1
Alam, N.A.2
Rowan, A.J.3
Barclay, E.4
Jaeger, E.E.5
Kelsell, D.6
-
61
-
-
9144249602
-
Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma
-
Vanharanta S., Buchta M., McWhinney S.R., Virta S.K., Peczkowska M., Morrison C.D., et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 2004, 74:153-159.
-
(2004)
Am J Hum Genet
, vol.74
, pp. 153-159
-
-
Vanharanta, S.1
Buchta, M.2
McWhinney, S.R.3
Virta, S.K.4
Peczkowska, M.5
Morrison, C.D.6
-
62
-
-
52949127312
-
An integrated genomic analysis of human glioblastoma multiforme
-
Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., Angenendt P., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812.
-
(2008)
Science
, vol.321
, pp. 1807-1812
-
-
Parsons, D.W.1
Jones, S.2
Zhang, X.3
Lin, J.C.4
Leary, R.J.5
Angenendt, P.6
-
63
-
-
77953702324
-
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
-
Dang L., White D.W., Gross S., Bennett B.D., Bittinger M.A., Driggers E.M., et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2010, 465:966.
-
(2010)
Nature
, vol.465
, pp. 966
-
-
Dang, L.1
White, D.W.2
Gross, S.3
Bennett, B.D.4
Bittinger, M.A.5
Driggers, E.M.6
-
64
-
-
77955907891
-
IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication
-
Paschka P., Schlenk R.F., Gaidzik V.I., Habdank M., Kronke J., Bullinger L., et al. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. J Clin Oncol 2010, 28:3636-3643.
-
(2010)
J Clin Oncol
, vol.28
, pp. 3636-3643
-
-
Paschka, P.1
Schlenk, R.F.2
Gaidzik, V.I.3
Habdank, M.4
Kronke, J.5
Bullinger, L.6
-
65
-
-
33344456073
-
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted
-
Langbein S., Zerilli M., Zur H.A., Staiger W., Rensch-Boschert K., Lukan N., et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer 2006, 94:578-585.
-
(2006)
Br J Cancer
, vol.94
, pp. 578-585
-
-
Langbein, S.1
Zerilli, M.2
Zur, H.A.3
Staiger, W.4
Rensch-Boschert, K.5
Lukan, N.6
-
66
-
-
45349105721
-
Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: a potential therapeutic target in nasopharyngeal carcinoma
-
Zhang S., Yue J.X., Yang J.H., Cai P.C., Kong W.J. Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: a potential therapeutic target in nasopharyngeal carcinoma. Cancer Biol Ther 2008, 7:517-522.
-
(2008)
Cancer Biol Ther
, vol.7
, pp. 517-522
-
-
Zhang, S.1
Yue, J.X.2
Yang, J.H.3
Cai, P.C.4
Kong, W.J.5
-
67
-
-
84858208795
-
Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression
-
Kayser G., Sienel W., Kubitz B., Mattern D., Stickeler E., Passlick B., et al. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression. Pathology 2011, 43:719-724.
-
(2011)
Pathology
, vol.43
, pp. 719-724
-
-
Kayser, G.1
Sienel, W.2
Kubitz, B.3
Mattern, D.4
Stickeler, E.5
Passlick, B.6
-
68
-
-
80053206983
-
Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation
-
Diaz-Moralli S., Tarrado-Castellarnau M., Alenda C., Castells A., Cascante M. Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation. PLoS One 2011, 6:e25323.
-
(2011)
PLoS One
, vol.6
-
-
Diaz-Moralli, S.1
Tarrado-Castellarnau, M.2
Alenda, C.3
Castells, A.4
Cascante, M.5
-
69
-
-
77954162688
-
Glucose metabolism of malignant cells is not regulated by transketolase-like (TKTL)-1
-
Mayer A., von Wallbrunn A., Vaupel P. Glucose metabolism of malignant cells is not regulated by transketolase-like (TKTL)-1. Int J Oncol 2010, 37:265-271.
-
(2010)
Int J Oncol
, vol.37
, pp. 265-271
-
-
Mayer, A.1
von Wallbrunn, A.2
Vaupel, P.3
-
70
-
-
0030758923
-
Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation
-
Boros L.G., Puigjaner J., Cascante M., Lee W.N., Brandes J.L., Bassilian S., et al. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res 1997, 57:4242-4248.
-
(1997)
Cancer Res
, vol.57
, pp. 4242-4248
-
-
Boros, L.G.1
Puigjaner, J.2
Cascante, M.3
Lee, W.N.4
Brandes, J.L.5
Bassilian, S.6
-
71
-
-
0032797579
-
Alterations in the glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells
-
Mazurek S., Eigenbrodt E., Failing K., Steinberg P. Alterations in the glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells. J Cell Physiol 1999, 181:136-146.
-
(1999)
J Cell Physiol
, vol.181
, pp. 136-146
-
-
Mazurek, S.1
Eigenbrodt, E.2
Failing, K.3
Steinberg, P.4
-
72
-
-
57749088701
-
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
-
Wise D.R., DeBerardinis R.J., Mancuso A., Sayed N., Zhang X.Y., Pfeiffer H.K., et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 2008, 105:18782-18787.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 18782-18787
-
-
Wise, D.R.1
DeBerardinis, R.J.2
Mancuso, A.3
Sayed, N.4
Zhang, X.Y.5
Pfeiffer, H.K.6
-
73
-
-
0028284966
-
Phosphate-activated glutaminase expression during tumor development
-
Aledo J.C., Segura J.A., Medina M.A., Alonso F.J., Nunez de Castro I., Marquez J. Phosphate-activated glutaminase expression during tumor development. FEBS Lett. 1994, 341:39-42.
-
(1994)
FEBS Lett.
, vol.341
, pp. 39-42
-
-
Aledo, J.C.1
Segura, J.A.2
Medina, M.A.3
Alonso, F.J.4
Nunez de Castro, I.5
Marquez, J.6
-
74
-
-
0023265237
-
Elevated plasma glutamate levels in colorectal carcinoma patients and in patients with acquired immunodeficiency syndrome (AIDS)
-
Droge W., Eck H.P., Betzler M., Naher H. Elevated plasma glutamate levels in colorectal carcinoma patients and in patients with acquired immunodeficiency syndrome (AIDS). Immunobiology 1987, 174:473-479.
-
(1987)
Immunobiology
, vol.174
, pp. 473-479
-
-
Droge, W.1
Eck, H.P.2
Betzler, M.3
Naher, H.4
-
75
-
-
80053112410
-
New role of glutamate as an immunoregulator via glutamate receptors and transporters
-
Xue H., Field C.J. New role of glutamate as an immunoregulator via glutamate receptors and transporters. Front Biosci (Schol Ed) 2011, 3:1007-1020.
-
(2011)
Front Biosci (Schol Ed)
, vol.3
, pp. 1007-1020
-
-
Xue, H.1
Field, C.J.2
-
76
-
-
0142137237
-
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
-
Uyttenhove C., Pilotte L., Theate I., Stroobant V., Colau D., Parmentier N., et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 2003, 9:1269-1274.
-
(2003)
Nat Med
, vol.9
, pp. 1269-1274
-
-
Uyttenhove, C.1
Pilotte, L.2
Theate, I.3
Stroobant, V.4
Colau, D.5
Parmentier, N.6
-
77
-
-
54849418903
-
IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism
-
Lob S., Konigsrainer A., Zieker D., Brucher B.L., Rammensee H.G., Opelz G., et al. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. Cancer Immunol Immunother 2009, 58:153-157.
-
(2009)
Cancer Immunol Immunother
, vol.58
, pp. 153-157
-
-
Lob, S.1
Konigsrainer, A.2
Zieker, D.3
Brucher, B.L.4
Rammensee, H.G.5
Opelz, G.6
-
78
-
-
62149114893
-
Nicotinamide adenine dinucleotide biology and disease
-
Penberthy W.T. Nicotinamide adenine dinucleotide biology and disease. Curr Pharm Des 2009, 15:1-2.
-
(2009)
Curr Pharm Des
, vol.15
, pp. 1-2
-
-
Penberthy, W.T.1
-
79
-
-
33845920042
-
Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients
-
Weinlich G., Murr C., Richardsen L., Winkler C., Fuchs D. Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients. Dermatology 2007, 214:8-14.
-
(2007)
Dermatology
, vol.214
, pp. 8-14
-
-
Weinlich, G.1
Murr, C.2
Richardsen, L.3
Winkler, C.4
Fuchs, D.5
-
80
-
-
33644775726
-
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells
-
Brandacher G., Perathoner A., Ladurner R., Schneeberger S., Obrist P., Winkler C., et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res 2006, 12:1144-1151.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 1144-1151
-
-
Brandacher, G.1
Perathoner, A.2
Ladurner, R.3
Schneeberger, S.4
Obrist, P.5
Winkler, C.6
-
81
-
-
37249048334
-
Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma
-
Riesenberg R., Weiler C., Spring O., Eder M., Buchner A., Popp T., et al. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma. Clin Cancer Res 2007, 13:6993-7002.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 6993-7002
-
-
Riesenberg, R.1
Weiler, C.2
Spring, O.3
Eder, M.4
Buchner, A.5
Popp, T.6
-
82
-
-
34548604258
-
Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells
-
Haniffa M.A., Wang X.N., Holtick U., Rae M., Isaacs J.D., Dickinson A.M., et al. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 2007, 179:1595-1604.
-
(2007)
J Immunol
, vol.179
, pp. 1595-1604
-
-
Haniffa, M.A.1
Wang, X.N.2
Holtick, U.3
Rae, M.4
Isaacs, J.D.5
Dickinson, A.M.6
-
83
-
-
0032555614
-
Prevention of allogeneic fetal rejection by tryptophan catabolism
-
Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998, 281:1191-1193.
-
(1998)
Science
, vol.281
, pp. 1191-1193
-
-
Munn, D.H.1
Zhou, M.2
Attwood, J.T.3
Bondarev, I.4
Conway, S.J.5
Marshall, B.6
-
84
-
-
0038215374
-
Tolerance, DCs and tryptophan: much ado about IDO
-
Grohmann U., Fallarino F., Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 2003, 24:242-248.
-
(2003)
Trends Immunol
, vol.24
, pp. 242-248
-
-
Grohmann, U.1
Fallarino, F.2
Puccetti, P.3
-
85
-
-
84863012436
-
Activated CD69+ T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages
-
Zhao Q., Kuang D.M., Wu Y., Xiao X., Li X.F., Li T.J., et al. Activated CD69+ T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages. J Immunol 2012, 188:1117-1124.
-
(2012)
J Immunol
, vol.188
, pp. 1117-1124
-
-
Zhao, Q.1
Kuang, D.M.2
Wu, Y.3
Xiao, X.4
Li, X.F.5
Li, T.J.6
-
86
-
-
80054032526
-
Cancer: why tumours eat tryptophan
-
Prendergast G.C. Cancer: why tumours eat tryptophan. Nature 2011, 478:192-194.
-
(2011)
Nature
, vol.478
, pp. 192-194
-
-
Prendergast, G.C.1
-
87
-
-
33646893538
-
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells
-
Fallarino F., Grohmann U., You S., McGrath B.C., Cavener D.R., Vacca C., et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 2006, 176:6752-6761.
-
(2006)
J Immunol
, vol.176
, pp. 6752-6761
-
-
Fallarino, F.1
Grohmann, U.2
You, S.3
McGrath, B.C.4
Cavener, D.R.5
Vacca, C.6
-
88
-
-
32944468867
-
Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines
-
Weber W.P., Feder-Mengus C., Chiarugi A., Rosenthal R., Reschner A., Schumacher R., et al. Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines. Eur J Immunol 2006, 36:296-304.
-
(2006)
Eur J Immunol
, vol.36
, pp. 296-304
-
-
Weber, W.P.1
Feder-Mengus, C.2
Chiarugi, A.3
Rosenthal, R.4
Reschner, A.5
Schumacher, R.6
-
89
-
-
67650422617
-
Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer
-
Qian F., Villella J., Wallace P.K., Mhawech-Fauceglia P., Tario J.D., Andrews C., et al. Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer. Cancer Res 2009, 69:5498-5504.
-
(2009)
Cancer Res
, vol.69
, pp. 5498-5504
-
-
Qian, F.1
Villella, J.2
Wallace, P.K.3
Mhawech-Fauceglia, P.4
Tario, J.D.5
Andrews, C.6
-
90
-
-
33749537279
-
Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference
-
Zheng X., Koropatnick J., Li M., Zhang X., Ling F., Ren X., et al. Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference. J Immunol 2006, 177:5639-5646.
-
(2006)
J Immunol
, vol.177
, pp. 5639-5646
-
-
Zheng, X.1
Koropatnick, J.2
Li, M.3
Zhang, X.4
Ling, F.5
Ren, X.6
-
91
-
-
59449103002
-
A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA
-
Yen M.C., Lin C.C., Chen Y.L., Huang S.S., Yang H.J., Chang C.P., et al. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA. Clin Cancer Res 2009, 15:641-649.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 641-649
-
-
Yen, M.C.1
Lin, C.C.2
Chen, Y.L.3
Huang, S.S.4
Yang, H.J.5
Chang, C.P.6
-
92
-
-
16244408626
-
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
-
Muller A.J., Duhadaway J.B., Donover P.S., Sutanto-Ward E., Prendergast G.C. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med 2005, 11:312-319.
-
(2005)
Nat Med
, vol.11
, pp. 312-319
-
-
Muller, A.J.1
Duhadaway, J.B.2
Donover, P.S.3
Sutanto-Ward, E.4
Prendergast, G.C.5
-
93
-
-
47249139145
-
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression
-
Rotondo R., Mastracci L., Piazza T., Barisione G., Fabbi M., Cassanello M., et al. Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression. Int J Cancer 2008, 123:1108-1116.
-
(2008)
Int J Cancer
, vol.123
, pp. 1108-1116
-
-
Rotondo, R.1
Mastracci, L.2
Piazza, T.3
Barisione, G.4
Fabbi, M.5
Cassanello, M.6
-
94
-
-
20144362409
-
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity
-
Munder M., Mollinedo F., Calafat J., Canchado J., Gil-Lamaignere C., Fuentes J.M., et al. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 2005, 105:2549-2556.
-
(2005)
Blood
, vol.105
, pp. 2549-2556
-
-
Munder, M.1
Mollinedo, F.2
Calafat, J.3
Canchado, J.4
Gil-Lamaignere, C.5
Fuentes, J.M.6
-
95
-
-
60549088732
-
Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes
-
Rodriguez P.C., Ernstoff M.S., Hernandez C., Atkins M., Zabaleta J., Sierra R., et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009, 69:1553-1560.
-
(2009)
Cancer Res
, vol.69
, pp. 1553-1560
-
-
Rodriguez, P.C.1
Ernstoff, M.S.2
Hernandez, C.3
Atkins, M.4
Zabaleta, J.5
Sierra, R.6
-
96
-
-
33846891555
-
Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma
-
Ochoa A.C., Zea A.H., Hernandez C., Rodriguez P.C. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 2007, 13:721s-726s.
-
(2007)
Clin Cancer Res
, vol.13
-
-
Ochoa, A.C.1
Zea, A.H.2
Hernandez, C.3
Rodriguez, P.C.4
-
97
-
-
20944434107
-
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
-
Bronte V., Kasic T., Gri G., Gallana K., Borsellino G., Marigo I., et al. Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. J Exp Med 2005, 201:1257-1268.
-
(2005)
J Exp Med
, vol.201
, pp. 1257-1268
-
-
Bronte, V.1
Kasic, T.2
Gri, G.3
Gallana, K.4
Borsellino, G.5
Marigo, I.6
-
98
-
-
2142695733
-
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
-
Warner T.D., Mitchell J.A. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 2004, 18:790-804.
-
(2004)
FASEB J
, vol.18
, pp. 790-804
-
-
Warner, T.D.1
Mitchell, J.A.2
-
99
-
-
4143134276
-
Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma
-
Denkert C., Weichert W., Winzer K.J., Muller B.M., Noske A., Niesporek S., et al. Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin Cancer Res 2004, 10:5580-5586.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5580-5586
-
-
Denkert, C.1
Weichert, W.2
Winzer, K.J.3
Muller, B.M.4
Noske, A.5
Niesporek, S.6
-
100
-
-
33746123520
-
Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia
-
Kaidi A., Qualtrough D., Williams A.C., Paraskeva C. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res 2006, 66:6683-6691.
-
(2006)
Cancer Res
, vol.66
, pp. 6683-6691
-
-
Kaidi, A.1
Qualtrough, D.2
Williams, A.C.3
Paraskeva, C.4
-
101
-
-
0034161878
-
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
-
Masferrer J.L., Leahy K.M., Koki A.T., Zweifel B.S., Settle S.L., Woerner B.M., et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000, 60:1306-1311.
-
(2000)
Cancer Res
, vol.60
, pp. 1306-1311
-
-
Masferrer, J.L.1
Leahy, K.M.2
Koki, A.T.3
Zweifel, B.S.4
Settle, S.L.5
Woerner, B.M.6
-
102
-
-
0037089506
-
Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer
-
Kundu N., Fulton A.M. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer. Cancer Res 2002, 62:2343-2346.
-
(2002)
Cancer Res
, vol.62
, pp. 2343-2346
-
-
Kundu, N.1
Fulton, A.M.2
-
103
-
-
25844501447
-
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
-
Rodriguez P.C., Hernandez C.P., Quiceno D., Dubinett S.M., Zabaleta J., Ochoa J.B., et al. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med 2005, 202:931-939.
-
(2005)
J Exp Med
, vol.202
, pp. 931-939
-
-
Rodriguez, P.C.1
Hernandez, C.P.2
Quiceno, D.3
Dubinett, S.M.4
Zabaleta, J.5
Ochoa, J.B.6
-
104
-
-
79953324535
-
COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells
-
Fujita M., Kohanbash G., Fellows-Mayle W., Hamilton R.L., Komohara Y., Decker S.A., et al. COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Res 2011, 71:2664-2674.
-
(2011)
Cancer Res
, vol.71
, pp. 2664-2674
-
-
Fujita, M.1
Kohanbash, G.2
Fellows-Mayle, W.3
Hamilton, R.L.4
Komohara, Y.5
Decker, S.A.6
-
105
-
-
77956473075
-
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
-
Veltman J.D., Lambers M.E., van Nimwegen M., Hendriks R.W., Hoogsteden H.C., Aerts J.G., et al. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function. BMC Cancer 2010, 10:464.
-
(2010)
BMC Cancer
, vol.10
, pp. 464
-
-
Veltman, J.D.1
Lambers, M.E.2
van Nimwegen, M.3
Hendriks, R.W.4
Hoogsteden, H.C.5
Aerts, J.G.6
-
106
-
-
33947225356
-
Physiological roles for ecto-5'-nucleotidase (CD73)
-
Colgan S.P., Eltzschig H.K., Eckle T., Thompson L.F. Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2006, 2:351-360.
-
(2006)
Purinergic Signal
, vol.2
, pp. 351-360
-
-
Colgan, S.P.1
Eltzschig, H.K.2
Eckle, T.3
Thompson, L.F.4
-
107
-
-
0031933227
-
Ecto-enzyme and signaling functions of lymphocyte CD73
-
Resta R., Yamashita Y., Thompson L.F. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 1998, 161:95-109.
-
(1998)
Immunol Rev
, vol.161
, pp. 95-109
-
-
Resta, R.1
Yamashita, Y.2
Thompson, L.F.3
-
108
-
-
85047685683
-
Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia
-
Synnestvedt K., Furuta G.T., Comerford K.M., Louis N., Karhausen J., Eltzschig H.K., et al. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002, 110:993-1002.
-
(2002)
J Clin Invest
, vol.110
, pp. 993-1002
-
-
Synnestvedt, K.1
Furuta, G.T.2
Comerford, K.M.3
Louis, N.4
Karhausen, J.5
Eltzschig, H.K.6
-
109
-
-
67651161862
-
Adenosine: an endogenous modulator of innate immune system with therapeutic potential
-
Kumar V., Sharma A. Adenosine: an endogenous modulator of innate immune system with therapeutic potential. Eur J Pharmacol 2009, 616:7-15.
-
(2009)
Eur J Pharmacol
, vol.616
, pp. 7-15
-
-
Kumar, V.1
Sharma, A.2
-
110
-
-
77957564570
-
Extracellular adenosine triphosphate and adenosine in cancer
-
Stagg J., Smyth M.J. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010, 29:5346-5358.
-
(2010)
Oncogene
, vol.29
, pp. 5346-5358
-
-
Stagg, J.1
Smyth, M.J.2
-
111
-
-
77956254094
-
Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells
-
Mandapathil M., Szczepanski M.J., Szajnik M., Ren J., Jackson E.K., Johnson J.T., et al. Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells. J Biol Chem 2010, 285:27571-27580.
-
(2010)
J Biol Chem
, vol.285
, pp. 27571-27580
-
-
Mandapathil, M.1
Szczepanski, M.J.2
Szajnik, M.3
Ren, J.4
Jackson, E.K.5
Johnson, J.T.6
-
112
-
-
75949112218
-
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
-
Stagg J., Divisekera U., McLaughlin N., Sharkey J., Pommey S., Denoyer D., et al. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci USA 2010, 107:1547-1552.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 1547-1552
-
-
Stagg, J.1
Divisekera, U.2
McLaughlin, N.3
Sharkey, J.4
Pommey, S.5
Denoyer, D.6
-
113
-
-
84855408091
-
Adenosine A2B receptor blockade slows growth of bladder and breast tumors
-
Cekic C., Sag D., Li Y., Theodorescu D., Strieter R.M., Linden J. Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J Immunol 2012, 188:198-205.
-
(2012)
J Immunol
, vol.188
, pp. 198-205
-
-
Cekic, C.1
Sag, D.2
Li, Y.3
Theodorescu, D.4
Strieter, R.M.5
Linden, J.6
-
114
-
-
56249134513
-
Quantitative analysis of 5'-deoxy-5'-methylthioadenosine in melanoma cells by liquid chromatography-stable isotope ratio tandem mass spectrometry
-
Stevens A.P., Dettmer K., Wallner S., Bosserhoff A.K., Oefner P.J. Quantitative analysis of 5'-deoxy-5'-methylthioadenosine in melanoma cells by liquid chromatography-stable isotope ratio tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 876:123-128.
-
(2008)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.876
, pp. 123-128
-
-
Stevens, A.P.1
Dettmer, K.2
Wallner, S.3
Bosserhoff, A.K.4
Oefner, P.J.5
-
115
-
-
29744437726
-
Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma
-
Hellerbrand C., Muhlbauer M., Wallner S., Schuierer M., Behrmann I., Bataille F., et al. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. Carcinogenesis 2006, 27:64-72.
-
(2006)
Carcinogenesis
, vol.27
, pp. 64-72
-
-
Hellerbrand, C.1
Muhlbauer, M.2
Wallner, S.3
Schuierer, M.4
Behrmann, I.5
Bataille, F.6
-
116
-
-
0042846001
-
Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma
-
Behrmann I., Wallner S., Komyod W., Heinrich P.C., Schuierer M., Buettner R., et al. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma. Am J Pathol 2003, 163:683-690.
-
(2003)
Am J Pathol
, vol.163
, pp. 683-690
-
-
Behrmann, I.1
Wallner, S.2
Komyod, W.3
Heinrich, P.C.4
Schuierer, M.5
Buettner, R.6
-
117
-
-
34250306444
-
A potential predictive marker for response to interferon in malignant melanoma
-
Wild P.J., Meyer S., Landthaler M., Hofstaedter F., Bosserhoff A.K. A potential predictive marker for response to interferon in malignant melanoma. J Dtsch Dermatol Ges 2007, 5:456-459.
-
(2007)
J Dtsch Dermatol Ges
, vol.5
, pp. 456-459
-
-
Wild, P.J.1
Meyer, S.2
Landthaler, M.3
Hofstaedter, F.4
Bosserhoff, A.K.5
-
118
-
-
77949967131
-
Targeting metabolic transformation for cancer therapy
-
Tennant D.A., Duran R.V., Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010, 10:267-277.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 267-277
-
-
Tennant, D.A.1
Duran, R.V.2
Gottlieb, E.3
-
119
-
-
19344377474
-
GCN2 kinase in T-cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
-
Munn D.H., Sharma M.D., Baban B., Harding H.P., Zhang Y., Ron D., et al. GCN2 kinase in T-cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 2005, 22:633-642.
-
(2005)
Immunity
, vol.22
, pp. 633-642
-
-
Munn, D.H.1
Sharma, M.D.2
Baban, B.3
Harding, H.P.4
Zhang, Y.5
Ron, D.6
-
120
-
-
0038519365
-
L-Arginine metabolism in myeloid cells controls T-lymphocyte functions
-
Bronte V., Serafini P., Mazzoni A., Segal D.M., Zanovello P. l-Arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 2003, 24:302-306.
-
(2003)
Trends Immunol
, vol.24
, pp. 302-306
-
-
Bronte, V.1
Serafini, P.2
Mazzoni, A.3
Segal, D.M.4
Zanovello, P.5
-
121
-
-
38749111823
-
MTOR as a target for therapy of renal cancer
-
Hudes G.R. mTOR as a target for therapy of renal cancer. Clin Adv Hematol Oncol 2007, 5:772-774.
-
(2007)
Clin Adv Hematol Oncol
, vol.5
, pp. 772-774
-
-
Hudes, G.R.1
-
122
-
-
38349092288
-
Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha
-
Koh M.Y., Spivak-Kroizman T., Venturini S., Welsh S., Williams R.R., Kirkpatrick D.L., et al. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha. Mol Cancer Ther 2008, 7:90-100.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 90-100
-
-
Koh, M.Y.1
Spivak-Kroizman, T.2
Venturini, S.3
Welsh, S.4
Williams, R.R.5
Kirkpatrick, D.L.6
-
123
-
-
77955656201
-
LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line
-
Lee K., Kang J.E., Park S.K., Jin Y., Chung K.S., Kim H.M., et al. LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line. Biochem Pharmacol 2010, 80:982-989.
-
(2010)
Biochem Pharmacol
, vol.80
, pp. 982-989
-
-
Lee, K.1
Kang, J.E.2
Park, S.K.3
Jin, Y.4
Chung, K.S.5
Kim, H.M.6
-
124
-
-
0042343801
-
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
-
Yang J.C., Haworth L., Sherry R.M., Hwu P., Schwartzentruber D.J., Topalian S.L., et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 2003, 349:427-434.
-
(2003)
N Engl J Med
, vol.349
, pp. 427-434
-
-
Yang, J.C.1
Haworth, L.2
Sherry, R.M.3
Hwu, P.4
Schwartzentruber, D.J.5
Topalian, S.L.6
-
125
-
-
70450230486
-
Low doses of 2-deoxy-glucose sensitize acute lymphoblastic leukemia cells to glucocorticoid-induced apoptosis
-
Eberhart K., Renner K., Ritter I., Kastenberger M., Singer K., Hellerbrand C., et al. Low doses of 2-deoxy-glucose sensitize acute lymphoblastic leukemia cells to glucocorticoid-induced apoptosis. Leukemia 2009, 23:2167-2170.
-
(2009)
Leukemia
, vol.23
, pp. 2167-2170
-
-
Eberhart, K.1
Renner, K.2
Ritter, I.3
Kastenberger, M.4
Singer, K.5
Hellerbrand, C.6
-
126
-
-
23044507635
-
Optimizing cancer radiotherapy with 2-deoxy-d-glucose
-
Singh D., Banerji A.K., Dwarakanath B.S., Tripathi R.P., Gupta J.P., Mathew T.L., et al. Optimizing cancer radiotherapy with 2-deoxy-d-glucose. Strahlenther Onkol 2005, 181:505-514.
-
(2005)
Strahlenther Onkol
, vol.181
, pp. 505-514
-
-
Singh, D.1
Banerji, A.K.2
Dwarakanath, B.S.3
Tripathi, R.P.4
Gupta, J.P.5
Mathew, T.L.6
-
127
-
-
5144225468
-
Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells
-
Gottschalk S., Anderson N., Hainz C., Eckhardt S.G., Serkova N.J. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Clin Cancer Res 2004, 10:6661-6668.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 6661-6668
-
-
Gottschalk, S.1
Anderson, N.2
Hainz, C.3
Eckhardt, S.G.4
Serkova, N.J.5
|